CLYM vs TBPH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 31, 2026

CLYM

55.6
AI Score
VS
CLYM Wins

TBPH

55.1
AI Score

Investment Advisor Scores

CLYM

56score
Recommendation
HOLD

TBPH

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLYM TBPH Winner
Net Income -13.72M 105.89M TBPH
Operating Income -15.21M -3.60M TBPH
ROE -9.3% 35.7% TBPH
ROA -9.0% 21.8% TBPH
Total Assets 152.37M 485.57M TBPH
Cash 8.36M 167.81M TBPH
Current Ratio 27.86 10.93 CLYM

Relative Price Performance (Last 90 Days)

CLYM 1M: -5.4% · 3M: +29.6% TBPH 1M: -0.7% · 3M: -0.2%

Current Technical Phase

CLYM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.6% over 20 days), RSI 51

RSI (14): 51.1 · Price: $12.56

TBPH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 51

RSI (14): 51.5 · Price: $16.88

Fundamentals Snapshot

Metric CLYM TBPH
Market Cap
Forward P/E -11.1 21.1
Trailing P/E 7.6
Revenue (TTM)
Revenue Growth 0.0% 0.2%
Gross Margin 0.7%
Operating Margin 0.0% -0.3%
EPS -0.77 2.23
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.